<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption> Table 9. Summary of Mean (±Standard Deviation) Irinotecan and SN-38</caption>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<td align="center" colspan="9" valign="top"> <content stylecode="bold">Pharmacokinetic Parameters in Patients with Solid Tumors</content>
</td>
</tr>
<tr>
<td align="center"> </td>
<td align="center" colspan="5" valign="top">  Irinotecan</td>
<td align="center" colspan="3" valign="top">  SN-38</td>
</tr>
<tr>
<td align="center">  Dose</td>
<td align="center">  C<sub>max</sub>
</td>
<td align="center">  AUC<sub>0-24</sub>
</td>
<td align="center">  t<sub>1/2</sub>
</td>
<td align="center">  V<sub>z</sub>
</td>
<td align="center">  CL</td>
<td align="center">  C<sub>max</sub>
</td>
<td align="center">  AUC<sub>0-24</sub>
</td>
<td align="center">  t<sub>1/2 </sub>
</td>
</tr>
<tr>
<td align="center">  (mg/ m<sup>2</sup>)</td>
<td align="center">  (ng/mL)</td>
<td align="center">  (ng·h/mL)</td>
<td align="center">  (h)</td>
<td align="center">  L/m<sup>2</sup>)</td>
<td align="center">  (L/h/m<sup>2</sup>)</td>
<td align="center">  (ng/mL)</td>
<td align="center">  (ng·h/ mL)</td>
<td align="center">  (h)</td>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="9" valign="top">  C<sub>max</sub> - Maximum plasma concentration  </td>
</tr>
<tr>
<td colspan="9" valign="top">  AUC<sub>0-24 </sub>- Area under the plasma concentration-time curve from time  </td>
</tr>
<tr>
<td colspan="9" valign="top">                 0 to 24 hours after the end of the 90-minute infusion  </td>
</tr>
<tr>
<td colspan="9" valign="top">  t<sub>1/2</sub> - Terminal elimination half-life  </td>
</tr>
<tr>
<td colspan="9" valign="top">  V<sub>z</sub> - Volume of distribution of terminal elimination phase  </td>
</tr>
<tr>
<td colspan="9" valign="top">  CL - Total systemic clearance  </td>
</tr>
<tr>
<td colspan="9" valign="top"> <sup>a</sup> Plasma specimens collected for 24 hours following the end of the 90-minute infusion.  </td>
</tr>
<tr>
<td colspan="9" valign="top"> <sup>b</sup> Plasma specimens collected for 48 hours following the end of the 90-minute infusion. Because of the longer collection period, these values provide a more accurate reflection of the terminal elimination half-lives of irinotecan and SN-38.  </td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center"> 125</td>
<td align="center"> 1,660</td>
<td align="center"> 10,200 </td>
<td align="center"> 5.8<sup>a</sup>
</td>
<td align="center"> 110 </td>
<td align="center"> 13.3 </td>
<td align="center"> 26.3 </td>
<td align="center"> 229 </td>
<td align="center"> 10.4<sup>a </sup>
</td>
</tr>
<tr>
<td align="center"> (N=64)</td>
<td align="center"> ±797</td>
<td align="center"> ±3,270</td>
<td align="center"> ±0.7</td>
<td align="center"> ±48.5</td>
<td align="center"> ±6.01</td>
<td align="center"> ±11.9</td>
<td align="center"> ±108</td>
<td align="center"> ±3.1</td>
</tr>
<tr>
<td align="center" valign="top"> 340 </td>
<td align="center" valign="top"> 3,392 </td>
<td align="center" valign="top"> 20,604 </td>
<td align="center" valign="top"> 11.7<sup>b</sup>
</td>
<td align="center" valign="top"> 234 </td>
<td align="center" valign="top"> 13.9 </td>
<td align="center" valign="top"> 56.0 </td>
<td align="center" valign="top"> 474 </td>
<td align="center" valign="top"> 21.0<sup>b </sup>
</td>
</tr>
<tr>
<td align="center" valign="top"> (N=6)</td>
<td align="center" valign="top"> ±874</td>
<td align="center" valign="top"> ±6,027</td>
<td align="center" valign="top"> ±1.0</td>
<td align="center" valign="top"> ±69.6</td>
<td align="center" valign="top"> ±4.0</td>
<td align="center" valign="top"> ±28.2</td>
<td align="center" valign="top"> ±245</td>
<td align="center" valign="top"> ±4.3</td>
</tr>
</tbody>
</table>